Trials / Unknown
UnknownNCT04915573
Antimicrobial Resistance in Cirrhotic Patients
Antimicrobial Resistance Among Sputum Pathogens in Post Hepatitis Cirrhotic Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Cirrhotic patients are more vulnerable to bacterial infection, and infection is one of the most common causes of acute liver disease decompensation.
Detailed description
Cirrhotic patients are more vulnerable to bacterial infection which is a common cause of acute liver disease decompensation. The aim of this study will characterize the antimicrobial resistance and distribution of bacteria isolated from chronic hepatic patients with pulmonary infections, as well as to evaluate the antimicrobial susceptibility of bacteria isolated from sputum.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Specimen | Sputum will be collected in clean disposable containers |
Timeline
- Start date
- 2021-06-07
- Primary completion
- 2021-09-01
- Completion
- 2021-09-01
- First posted
- 2021-06-07
- Last updated
- 2021-06-10
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04915573. Inclusion in this directory is not an endorsement.